Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Psychiatry
•
Child & Adolescent Psychiatry
•
General Psychiatry
When would you consider transdermal treatments for ADHD?
Related Questions
When do you use SNRIs or norepinephrine reuptake inhibitors (e.g., atomoxetine) for the treatment of ADHD?
What is the best way to manage low systolic blood pressures on clozapine when the patient has failed multiple other antipsychotic trials?
How do you approach neuromodulation in postpartum depression?
When do you consider using multiple antipsychotic medications for chronic management of psychosis?
Is there evidence to suggest there is a withdrawal syndrome from muscle relaxants such as tizanidine?
Would you consider over-the-counter dextromethorphan (low dose, slow titration) as augmentation in MDD?
How do you approach antidepressant choices for patients with generalized anxiety disorder when the patient reports excessive sedation on low doses of SSRIs?
Is there a benefit to augmenting treatment for schizophrenia by adding aripiprazole (a partial D2 agonist) to a full D2 antagonist such as haloperidol?
When and how do you taper antipsychotics after a resolved episode of bipolar mania with psychotic features?
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (prn) if/when symptoms develop?
